Intellia Therapeutics Inc [NASDAQ: NTLA] traded at a high on Tuesday, posting a 6.92 gain after which it closed the day’ session at $9.58.
The results of the trading session contributed to over 9930706 shares changing hands. Over the past one week, the price volatility of Intellia Therapeutics Inc stands at 4.33% while the volatility over the past one month is 7.49%.
The market cap for NTLA stock reached $992.33 million, with 103.54 million shares outstanding and 97.48 million shares in the current float. Compared to the average trading volume of 4.23M shares, NTLA reached a trading volume of 9930706 in the most recent trading day, which is why market watchdogs consider the stock to be active.
What do top market gurus say about Intellia Therapeutics Inc [NTLA]?
Based on careful and fact-backed analyses by Wall Street experts, the current consensus on the target price for NTLA shares is $36.84 per share. Analysis on target price and performance of stocks is usually carefully studied by market experts, and the current Wall Street consensus on NTLA stock is a recommendation set at 1.62. This rating represents a strong Buy recommendation, on the scale from 1 to 5, where 5 would mean strong sell, 4 represents Sell, 3 is Hold, and 2 indicates Buy.
Wolfe Research have made an estimate for Intellia Therapeutics Inc shares, keeping their opinion on the stock as Outperform, with their previous recommendation back on April 21, 2025. While these analysts kept the previous recommendation, H.C. Wainwright raised their target price to Buy. The new note on the price target was released on March 05, 2025, representing the official price target for Intellia Therapeutics Inc stock. Previously, the target price had yet another drop from $45 to $13, while JP Morgan kept a Neutral rating on NTLA stock.
The Average True Range (ATR) for Intellia Therapeutics Inc is set at 0.76, with the Price to Sales ratio for NTLA stock in the period of the last 12 months amounting to 21.78. The Price to Book ratio for the last quarter was 1.27, with the Price to Cash per share for the same quarter was set at 4.86.
How has NTLA stock performed recently?
Intellia Therapeutics Inc [NTLA] gain into the green zone at the end of the last week, gaining into a positive trend and gaining by 13.11. With this latest performance, NTLA shares gained by 12.71% in over the last four-week period, additionally sinking by -29.35% over the last 6 months – not to mention a drop of -63.10% in the past year of trading.
#####
Intellia Therapeutics Inc [NTLA]: Deeper insight into the fundamentals
Intellia Therapeutics Inc’s liquidity data is similarly interesting compelling, with a Quick Ratio of 4.90 and a Current Ratio set at 4.90.
Earnings analysis for Intellia Therapeutics Inc [NTLA]
The progress of the company may be observed through the prism of EPS growth rate, while Wall Street analysts are focusing on predicting the 5-year EPS growth rate for NTLA. When it comes to the mentioned value, analysts are expecting to see the 5-year EPS growth rate for Intellia Therapeutics Inc go to 31.48%.
Insider trade positions for Intellia Therapeutics Inc [NTLA]
The top three institutional holders of NTLA stocks are: ARK INVESTMENT MANAGEMENT LLC with ownership of 11.6 million shares, which is approximately 11.9575%. BLACKROCK INC., holding 9.6 million shares of the stock with an approximate value of $$214.79 million in NTLA stocks shares; and BLACKROCK INC., currently with $$203.66 million in NTLA stock with ownership which is approximately 9.3839%.
